| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 29 securities · passive | ||||||
|
WF Holding Limited
13G
WFF · G9627R107
|
9.9% |
10/21/2026
Event 10/14/2026
|
||||
|
DarkIris Inc.
13G/A
DKI · G2657S103
|
4.9% |
10/20/2026
Event 10/16/2026
|
||||
|
China SXT Pharmaceuticals, Inc.
13G
SXTC · G2161P157
|
9.9% |
10/15/2026
Event 10/8/2026
|
||||
|
Neo-Concept International Group Holdings Limited
13G
NCI · G6421C138
|
9.9% |
10/7/2026
Event 9/30/2026
|
||||
|
NFT Limited
13G/A
MI · G6363T123
|
4.9% |
9/29/2026
Event 9/23/2026
|
||||
|
Nuwellis, Inc.
13G/A
NUWE · 67113Y801
|
4.9% |
9/18/2026
Event 9/17/2026
|
||||
|
Singularity Future Technology Ltd.
13G/A
SGLY · 82935V406
|
4.9% |
9/10/2026
Event 8/28/2026
|
||||
|
Jupiter Neurosciences, Inc.
13G/A
JUNS · 48208B302
|
3.3% |
8/28/2026
Event 8/21/2026
|
||||
|
Elong Power Holding Limited
13G/A
ELPW · G3016G111
|
4.9% |
8/28/2026
Event 8/14/2026
|
||||
|
AIM ImmunoTech Inc.
13G
AIM · 00901B303
|
9.9% |
5/12/2026
Event 5/7/2026
|
||||
|
Healthcare Triangle, Inc.
13G/A
HCTI · 42227W405
|
0.2% |
3/5/2026
Event 3/4/2026
|
||||
|
Digital Currency X Technology Inc.
13G/A
DCX · G4465R129
|
0.6% |
2/5/2026
Event 12/31/2025
|
||||
|
AlphaTON Capital Corp
13G/A
ALP · G7185A136
|
4.5% |
2/3/2026
Event 1/28/2026
|
||||
|
Signing Day Sports, Inc.
13G/A
SGN · 82670R305
|
0% |
1/22/2026
Event 1/20/2026
|
||||
|
Phio Pharmaceuticals Corp.
13G/A
PHIO · 71880W501
|
4.9% |
12/11/2025
Event 12/8/2025
|
||||
|
Co-Diagnostics, Inc.
13G/A
CODX · 189763105
|
3.7% |
10/30/2025
Event 10/28/2025
|
||||
|
Silexion Therapeutics Corp
13G/A
SLXN · G1281K130
|
4.9% |
9/15/2025
Event 9/11/2025
|
||||
|
Purple Biotech Ltd.
13G/A
PPBT · 74638P208
|
4.9% |
9/9/2025
Event 9/4/2025
|
||||
|
Rani Therapeutics Holdings, Inc.
13G/A
RANI · 753018100
|
4.3% |
7/23/2025
Event 7/22/2025
|
||||
|
60 Degrees Pharmaceuticals, Inc.
13G/A
SXTP · 83006G401
|
4.9% |
7/17/2025
Event 7/15/2025
|
||||
|
Venus Concept Inc.
13G/A
VERO · 92332W303
|
4.9% |
6/11/2025
Event 6/6/2025
|
||||
|
Pasithea Therapeutics Corp.
13G/A
KTTA · 70261F202
|
4.9% |
5/9/2025
Event 5/7/2025
|
||||
|
Can-Fite BioPharma Ltd.
13G/A
CANF · 13471N300
|
4.1% |
4/23/2025
Event 4/22/2025
|
||||
|
Dogwood Therapeutics, Inc.
13G/A
DWTX · 92829J203
|
3.7% |
3/17/2025
Event 3/14/2025
|
||||
|
Lixte Biotechnology Holdings, Inc.
13G/A
NMAD · 539319301
|
4.5% |
2/18/2025
Event 2/14/2025
|
||||
|
Enveric Biosciences, Inc.
13G/A
ENVB · 29405E208
|
4.9% |
2/4/2025
Event 1/31/2025
|
||||
|
SuperCom Ltd.
13G/A
SPCB · M87095309
|
3.6% |
2/4/2025
Event 1/31/2025
|
||||
|
Singularity Future Technology Ltd.
13G/A
SGLY · 82935V307
|
0% |
2/3/2025
Event 1/31/2025
|
||||
|
Blue Hat Interactive Entertainment Technology
13G/A
BHAT · G1329V205
|
0% |
1/21/2025
Event 1/13/2025
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.